{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:22Z","timestamp":1792601542852,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Amniotic fluid embolism (AFE) is an uncommon pregnancy complication but is associated with high maternal mortality. Because of the rarity of AFE, associated risks factors and maternal outcomes have been relatively understudied.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the clinical, pregnancy, and delivery characteristics and the maternal outcomes related to AFE in a recent period in the US.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study examined hospital deliveries from January 1, 2016, to December 31, 2019, from the Healthcare Cost and Utilization Project\u2019s National Inpatient Sample.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was clinical, pregnancy, and delivery characteristics of AFE, assessed with a multivariable binary logistic regression model. The coprimary outcome was failure to rescue, defined as maternal mortality after AFE. Associations with other severe maternal morbidity indicators and failure to rescue per clinical and pregnancy characteristics were also assessed.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 14\u202f684\u202f135 deliveries were examined, with AFE diagnosed in 880 women, corresponding to an incidence rate of 6.0 per 100\u202f000 deliveries. The cohort-level median patient age was 29 years (IQR, 25-33 years). In a multivariable analysis, (1) patient factors of older age, Asian and Black race, Western US region, pregestational hypertension, asthma, illicit substance use, and grand multiparity; (2) pregnancy factors of placental accreta spectrum (PAS), placental abruption, uterine rupture, polyhydramnios, chorioamnionitis, preeclampsia, fetal growth restriction, and fetal demise; and (3) delivery factors of early gestational age, cervical ripening, cesarean delivery, operative delivery, and manual removal were associated with AFE. Among these characteristics, PAS had the largest association with AFE (adjusted odds ratio [aOR], 10.01; 95% CI, 7.03-14.24). When stratified by the PAS subtypes, more severe forms of PAS had a greater association with AFE (aOR for increta and percreta, 17.35; 95% CI, 10.21-28.48; and aOR for accreta, 7.62; 95% CI, 4.83-12.01). Patients who had AFE were more likely to have coagulopathy (aOR, 24.68; 95% CI, 19.38-31.44), cardiac arrest (aOR, 24.56; 95% CI, 17.84-33.81), and adult respiratory distress syndrome (aOR, 10.72; 95% CI, 8.09-14.20). The failure-to-rescue rate after AFE was 17.0% overall. However, the failure-to-rescue rate exceeded 30% when AFE co-occurred with other severe maternal morbidity indicators: 45.8% for AFE, cardiac arrest, and coagulopathy; 43.2% for AFE, shock, and cardiac rhythm conversion; and 38.6% for AFE, cardiac arrest, coagulopathy, and shock. The failure-to-rescue rate after AFE also exceeded 30% when AFE occurred in the setting of placental pathology: 42.9% for AFE and PAS and 31.3% for AFE and placental abruption.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This contemporaneous, national-level analysis validated previously known risk factors for AFE and confirmed the dismal outcomes of pregnancy complicated by AFE. The association between PAS and AFE, which was not previously reported, warrants further investigation.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.42842","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T16:30:58Z","timestamp":1668789058000},"page":"e2242842","source":"Crossref","is-referenced-by-count":74,"title":["Association of Pregnancy Characteristics and Maternal Mortality With Amniotic Fluid Embolism"],"prefix":"10.1001","volume":"5","author":[{"given":"Genevieve R.","family":"Mazza","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane C.","family":"Youssefzadeh","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Freiburg Faculty of Medicine, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kunze","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Freiburg Faculty of Medicine, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"},{"name":"Department of Gynecology, Osaka International Cancer Institute, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"},{"name":"Division of Reproductive Endocrinology & Infertility, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Ouzounian","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"},{"name":"Norris Comprehensive Cancer Center, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"5","key":"zoi221205r2","doi-asserted-by":"publisher","first-page":"445.e1","DOI":"10.1016\/j.ajog.2009.04.052","article-title":"Amniotic fluid embolism: an evidence-based review.","volume":"201","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi221205r3","doi-asserted-by":"publisher","first-page":"36.e1","DOI":"10.1016\/j.ajog.2008.03.007","article-title":"Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery.","volume":"199","author":"Clark","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi221205r4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjo.2016.123.issue-1","article-title":"Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study.","volume":"123","author":"Fitzpatrick","year":"2016","journal-title":"BJOG"},{"issue":"1","key":"zoi221205r5","doi-asserted-by":"publisher","first-page":"49.e1","DOI":"10.1016\/j.ajog.2007.11.061","article-title":"Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States.","volume":"199","author":"Abenhaim","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"zoi221205r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002962","article-title":"Risk factors, management, and outcomes of amniotic fluid embolism: a multicountry, population-based cohort and nested case-control study.","volume":"16","author":"Fitzpatrick","year":"2019","journal-title":"PLoS Med"},{"key":"zoi221205r7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2393-12-7","article-title":"Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations.","volume":"12","author":"Knight","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"zoi221205r8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/AOG.0b013e3181d9f629","article-title":"Incidence and risk factors for amniotic-fluid embolism.","volume":"115","author":"Knight","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"9545","key":"zoi221205r9","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(06)69607-4","article-title":"Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.","volume":"368","author":"Kramer","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"zoi221205r10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/j.1471-0528.2010.02656.x","article-title":"Amniotic fluid embolism in an Australian population-based cohort.","volume":"117","author":"Roberts","year":"2010","journal-title":"BJOG"},{"issue":"2","key":"zoi221205r11","doi-asserted-by":"publisher","first-page":"B16","DOI":"10.1016\/j.ajog.2016.03.012","article-title":"Amniotic fluid embolism: diagnosis and management.","volume":"215","author":"Pacheco","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi221205r12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajog.2016.06.037","article-title":"Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.","volume":"215","author":"Clark","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi221205r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2019.100083","article-title":"Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.","volume":"2","author":"Stafford","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2, pt 1","key":"zoi221205r14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/AOG.0000000000000107","article-title":"Amniotic fluid embolism.","volume":"123","author":"Clark","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi221205r15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ogc.2016.07.001","article-title":"Amniotic fluid embolism.","volume":"43","author":"Shamshirsaz","year":"2016","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"zoi221205r17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies.","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"issue":"6","key":"zoi221205r19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamasurg.2021.0600","article-title":"Decreasing failure-to-rescue from severe maternal morbidity at cesarean delivery: recent US trends.","volume":"156","author":"Matsuo","year":"2021","journal-title":"JAMA Surg"},{"issue":"2","key":"zoi221205r21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ije\/dyw040","article-title":"Outcome modelling strategies in epidemiology: traditional methods and basic alternatives.","volume":"45","author":"Greenland","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"2","key":"zoi221205r22","doi-asserted-by":"publisher","first-page":"255.e1","DOI":"10.1016\/j.ajog.2022.04.032","article-title":"Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasia.","volume":"227","author":"Matsuo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"zoi221205r23","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum.","volume":"378","author":"Silver","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi221205r24","first-page":"187","article-title":"Amniotic fluid embolism: definitive diagnosis in a survivor.","volume":"120","author":"Masson","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"2, pt 2","key":"zoi221205r25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/AOG.0b013e3181b5c8cc","article-title":"Anaphylactoid syndrome after intrauterine pressure catheter placement.","volume":"115","author":"Harbison","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi221205r26","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.ajog.2007.09.035","article-title":"Anaphylactoid syndrome of pregnancy immediately after intrauterine pressure catheter placement.","volume":"198","author":"Matsuo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi221205r27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ajog.2020.07.021","article-title":"Maternal mortality in the United States: research gaps, opportunities, and priorities.","volume":"223","author":"Chinn","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi221205r28","doi-asserted-by":"publisher","first-page":"B29","DOI":"10.1016\/j.ajog.2021.01.001","article-title":"Society for Maternal-Fetal Medicine Special Statement: checklist for initial management of amniotic fluid embolism.","volume":"224","author":"Combs","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi221205r29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajog.2019.07.036","article-title":"Amniotic fluid embolism: principles of early clinical management.","volume":"222","author":"Pacheco","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"zoi221205r30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.placenta.2022.02.021","article-title":"Second trimester uterine arteries pulsatility index is a function of placental pathology and provides insights on stillbirth aetiology: a multicenter matched case-control study.","volume":"121","author":"Amodeo","year":"2022","journal-title":"Placenta"},{"issue":"3","key":"zoi221205r31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ajog.2018.11.1099","article-title":"Evaluation of proposed criteria for research reporting of amniotic fluid embolism.","volume":"220","author":"Stafford","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"zoi221205r1","unstructured":"Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. Accessed May 14, 2022. https:\/\/www.cdc.gov\/reproductivehealth\/maternal-mortality\/pregnancy-mortality-surveillance-system.htm"},{"key":"zoi221205r16","unstructured":"Agency for Healthcare Research and Quality. Overview of the National (Nationwide) Inpatient Sample. Accessed May 8, 2022. https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"zoi221205r18","unstructured":"Centers for Disease Control and Prevention. How Does CDC Identify Severe Maternal Morbidity? Accessed May 8, 2022. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe-morbidity-ICD.htm"},{"key":"zoi221205r20","unstructured":"Elliott? M. ICD-10-PCS coding advice for labor induction. CMQCC. Accessed May 10, 2022. https:\/\/www.cmqcc.org\/sites\/default\/files\/ICD10%20Labor%20Induction%20FINAL_8.3.16.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798663\/mazza_2022_oi_221205_1668024599.90239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T16:31:01Z","timestamp":1668789061000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.42842","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}